WESTPORT, Conn.--(BUSINESS WIRE)--TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has appointed Bill Shields as Sr. Vice President of Sales and Business Development for its wholly owned subsidiary HemCon Medical Technologies Inc.
Mr. Shields, age 43, joins HemCon’s professional team to help drive growth and profits based on a new commitment to support sales and business development activities domestically and internationally, as well as focus the strategic direction of all global sales efforts and partner alliances. He brings extensive experience and a proven track record of growth over the course of 17 years from leading healthcare and medical device companies including IH Systems, Oligos Etc., Parata Systems and Epitope/OraSure Technologies.
Mr. Shields began his career as a market development and account sales representative with OraSure, a manufacturer and distributor of oral fluid diagnostic and collection devices based in Bethlehem, PA. He has held different positions of increasing responsibility through his career, most recently operating as the VP of Sales & Marketing for IH Systems, a Canadian pharmacy automation business. He has held positions with companies across the country and internationally. He graduated from SUNY New Paltz with a bachelor’s degree in business administration, marketing concentration and political science.
Barry Starkman, HemCon’s President and CEO, commented: “We are thrilled to have been able to attract a sales leader of Bill’s caliber. He has the experience and continuous track record of success that we need to regrow HemCon’s business—a business that brought the promise of hemostatic wound management technologies first to the battlefields of Iraq and Afghanistan and subsequently to the civilian markets. We expect that Bill will provide our growing sales team with the leadership necessary to dramatically increase our market share throughout the hemostatic and wound care space.”
John Linderman, President and CEO of TriStar Wellness Solutions, added, “TriStar Wellness Solutions is committed to engaging the best qualified managers to lead its business units. We seek out individuals that have solid industry experience combined with a strong bias for action and entrepreneurial business acumen. Bill represents the ideal leader for the HemCon business. Bill will be responsible for building an entire new team of sales professionals whose mission will be to drive market penetration of the HemCon product lines in the professional medical channel. Bill’s appointment at HemCon, along with Clemence Edelman’s recent appointment as Marketing Director at Beauté de MamanTM, underscore our commitment to growth.”
About TriStar Wellness Solutions
TriStar Wellness Solutions, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, health care solutions by leveraging proprietary innovation and technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beauté de MamanTM brand of women’s health products. Additional information is available at www.tstarwellness.com.
This press release for TriStar Wellness Solutions, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.